Página 3 - Melhores Cancro das amígdalas médicos - TOP-65 médicos

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

O Prof. Nail Paksoy é especialista no tratamento do cancro das amígdalas como Professor Associado no Hospital Medipol Bahçelievler, com vasta experiência em oncologia médica.

• Certificado pelo Conselho da ESMO em Oncologia Médica
• Envolvimento em 8 ensaios clínicos internacionais sobre tratamentos de cancro
• Publicação de inúmeros estudos em revistas de oncologia respeitadas

O Dr. Karatas é especialista em cirurgia de cabeça e pescoço, com extensa formação internacional na Europa e nos EUA.

• Formado em instituições de prestígio, incluindo a Hannover Medical School e a The Ohio State University
• Membro de múltiplas sociedades profissionais, incluindo a American Academy of Otolaryngology
• Especialista em técnicas cirúrgicas avançadas para patologias de cabeça e pescoço

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

O Dr. Sahibov é especialista em radioncologia, com formação na Universidade de Marmara, focando-se em tratamentos oncológicos precisos.

• Formação na Faculdade de Medicina da Universidade de Marmara
• Especialização em radioncologia de 2012 a 2016
• Proficiência em inglês, facilitando uma comunicação clara com os pacientes

O Dr. Raj Nagarkar realizou mais de 50.000 cirurgias oncológicas ao longo de 19 anos, com foco na melhoria da qualidade de vida dos pacientes.

• Formado em Oncologia Cirúrgica no Tata Memorial Hospital
• Fellowship no Royal College of Surgeons, Edimburgo
• Especializado em Oncologia Cirúrgica Mamária e Torácica
• Professor de Superespecialidade DNB em Oncologia Cirúrgica
• Envolvido em mais de 200 ensaios clínicos

Especialista em medicina nuclear que realizou mais de 30.000 exames de PET e tratou mais de 1.000 pacientes com cancro da tiroide no HCG Manavata Cancer Centre.

• 12 anos de experiência especializada em medicina nuclear
• Proficiência em exames nucleares avançados e imagens de PET-TC
• Especialização em terapias de iodo radioativo e Lu-177
• Investigador com publicações em revistas médicas

O Dr. Ozdemir traz mais de 30 anos de experiência em otorrinolaringologia e cirurgia de cabeça e pescoço, formado no Hacettepe University Medical Center – a principal faculdade de medicina da Turquia.

• Especializar-se em cirurgias de cabeça e pescoço, incluindo casos de cancro das amígdalas
• Ex-chefe do departamento de ORL da Universidade Namik Kemal
• Licenciar-se pela Faculdade de Medicina da Universidade de Hacettepe
• Atuar como instrutor no Hospital de Formação e Investigação Izmir Atatürk

O Dr. Sridhar P.S. especializa-se em radioterapia para cancro das amígdalas, com ampla formação e reconhecimento profissional.

• Mais de 20 anos de experiência em radioterapia
• Formado pela Banaras Hindu University – uma das principais instituições da Índia
• Membro da Association of Radiation Oncology of India
• Ativo na Society for Neuro-Oncology

O Dr. Ahmer Arif Shaikh é especialista em cirurgia de cancro oral e reabilitação funcional no HCG Manavata Cancer Centre.

• 3 anos de experiência em oncologia cirúrgica
• Especialização em preservação de órgãos para doentes com cancro oral
• Proficiência em grandes cirurgias maxilofaciais e de cabeça e pescoço
• Formação especializada (Fellowship) em Oncologia Cirúrgica de Cabeça e Pescoço
• Investigador publicado com foco em cancro oral